Single escalating dose trial of anivamersen-pegnivacogin [REG2] in healthy volunteers
Latest Information Update: 19 Feb 2014
At a glance
- Drugs Anivamersen-pegnivacogin (Primary)
- Indications Venous thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Regado Biosciences
- 19 Feb 2014 New trial record